Pharmacognosy Magazine

: 2020  |  Volume : 16  |  Issue : 70  |  Page : 236--245

Polyphenol-enriched fraction and the compounds isolated from Garcinia indica fruits ameliorate obesity through suppression of digestive enzymes and oxidative stress

Kavita Munjal1, Sheeraz Ahmad1, Apeksha Gupta2, Abdul Haye3, Saima Amin2, Showkat R Mir1,  
1 Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
2 Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
3 Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Correspondence Address:
Showkat R Mir
Phyto-Pharmaceuticals Research Laboratory, Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110 062


Background: The growing incidence of obesity has attracted the concern of researchers to look for effective interventions for its management. Garcinia indica is a widely known ethnomedicine used to treat gastritis, diabetes, and metabolic disorders. Recently, there has been a surge in the use of G. indica fruits in weight loss preparations. Objective: To explore the anti-obesity effect of polyphenol-enriched fraction and the compounds isolated from G. indica fruits through the inhibition of key metabolizing enzymes and oxidative stress. Materials and Methods: Fruits of G. indica were extracted with methanol that was subjected to liquid–liquid extraction to yield ethyl acetate fraction (FGIEF), chloroform, butanol, and aqueous fractions. The extract and the fractions were screened for the total polyphenols content (TPC), total flavonoids content (TFC), pancreatic lipase (PL) and α-amylase inhibition, and antioxidant activity. The effect of FGIEF on the viability of 3T3-L1 preadipocytes using 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide assay was assessed. FGIEF was subjected to normal-phase medium-pressure liquid chromatography (MPLC) to isolate compounds 1–3. Docking studies of representative polyphenols and the isolated compounds 1–3 with PL were undertaken to derive supporting evidence. Results: Among all the fractions, FGIEF was found to have the highest TPC (375.6 ± 4.5 gallic acid equivalent mg/g) and TFC (237.2 ± 6.2 quercetin equivalent mg/g). The extract and fractions showed concentration-dependent digestive enzyme inhibition and antioxidant effect. FGIEF inhibited PL and α-amylase (IC50values 257.3 ± 3.7 and 349.7 ± 5.8 μg/mL, respectively). FGIEF did not induce any cell death up to 800 μg/mL. MPLC of FGIEF led to the isolation of luteolin (1), napthyldioxolol (2), and oleantrienoic acid glucoside (3). Preferential inhibition by polyphenols compared to other compounds was notable in the docking studies. Conclusion: The study suggests that the fruits of G. indica exhibit anti-obesity effect through the inhibition of digestive enzymes that can be mainly attributed to the presence of polyphenols.

How to cite this article:
Munjal K, Ahmad S, Gupta A, Haye A, Amin S, Mir SR. Polyphenol-enriched fraction and the compounds isolated from Garcinia indica fruits ameliorate obesity through suppression of digestive enzymes and oxidative stress.Phcog Mag 2020;16:236-245

How to cite this URL:
Munjal K, Ahmad S, Gupta A, Haye A, Amin S, Mir SR. Polyphenol-enriched fraction and the compounds isolated from Garcinia indica fruits ameliorate obesity through suppression of digestive enzymes and oxidative stress. Phcog Mag [serial online] 2020 [cited 2020 Sep 26 ];16:236-245
Available from:

Full Text


  • Garcinia indica fruits, commonly known as Kokum , are used in many weight loss preparation
  • The fruits exhibit anti-obesity effect through the inhibition of fat and carbohydrate digestion
  • The fruit, particularly its polyphenol-rich fraction, reduces oxidative stress
  • This study establishes the beneficial effects of this fruit
  • This edible berry is recommended to be used as a dietary supplement.


Abbreviations used: MPLC: Medium-pressure liquid chromatography; PL: Pancreatic lipase; TPC: Total polyphenols content; TFC: Total flavonoids content; TLC: Thin layer chromatography; FGIEF: Fruits of G.indica Ethyl acetate fraction.


Obesity is a common nutritional disorder which is rapidly increasing among the population worldwide. This has now become a crucial factor for developing metabolic abnormalities, including atherosclerosis, insulin resistance, cardiovascular diseases, and cancer. As per the WHO, nearly 1.9 billion people were reported to be overweight whereas 650 million of them were obese. Genetic factors responsible for obesity account for only 5%–10% of obese individuals, and the major cause lies in positive calorie intake, sedentary lifestyles, and increased urbanization.[1] The first line of prevention/treatment approach is diet, exercise, and lifestyle modifications, but these often pose a challenge to implement in practice. Their failure to adequately control the condition leads to alternative treatment options, including drug intervention. However, several of the currently used agents are limited by their mechanism of action, side effects, compliance, and associated complications after the cessation of the drug.[2] Among the surgical options for obesity treatment, bariatric surgery helps in sustained weight loss for severely obese individuals, but it develops mental health problems associated with post-operative outcomes.[3]

The investigational research for anti-obesity medication is often aimed at the modulation of energy homeostasis by stimulating catabolic or inhibiting anabolic pathways. Calories intake mainly include fatty components (triglycerides) and carbohydrates. Two gastrointestinal enzymes, namely pancreatic lipase (PL) and α-amylase, are involved in the metabolism of fats and carbohydrates. PL hydrolyzes the triglycerides whereas α-amylase enzyme is accountable for the digestion of carbohydrates in the human body. The therapeutic approach to control obesity lies in the inhibition of these enzymes, so as to reduce the energy intake without altering central mechanisms.[4]

Fruits of Garcinia indica Choisy (Guttiferae ), commonly known as Kokum , have been used in Ayurveda to treat inflammatory ailments and metabolic disorders.[5] The fruit having tangy-sweet taste is a home remedy for acidity, sunstrokes, and infections.[6] It mainly contains polyphenols consisting of proanthocyanidins, anthocyanins, and flavonoids.[7] The major constituents include hydroxycitric acid (HCA); cyanidin glucoside and cyanidin sambubioside among anthocyanins;[8],[9] and polyisoprenylated benzophenones – garcinol, isogarcinol, and camboginol.[10] Garcinol, isogarcinol, and HCA are exclusively present in genus Garcinia ; however, catechins are also present in other plants. Rao et al ., 2010 have demonstrated the appetite suppressing activity of HCA lactone.[11] Lee et al ., 2019 reported that garcinol reduces obesity by diversifying gut microbiota constitution in high-fat diet-fed mice. In addition, garcinol also affects 5'-adenosine monophosphate-activated protein kinase pathway involved in adipogenesis and ultimately reducing cholesterol synthesis.[12] The curiosity in this remarkable fruit berry as a nutraceutical has amplified in recent years due to possible wholesome effects of its polyphenol content on health.[13] Many of therapeutic uses of G. indica fruits are associated to its antioxidant properties derived from phytochemicals majorly polyphenols. Polyphenolic antioxidants from dietary sources have been studied extensively for their role in lowering the incidences of cancer and cardiovascular and neurodegenerative diseases.[14] The purpose of this study was to assess the anti-obesity effect of polyphenol-enriched fraction of G. indica fruits by determining its effect on digestive enzymes (PL and amylase). Docking studies of the representative polyphenols as well as the compounds isolated from its fruits were undertaken to derive supporting evidence.

 Materials and Methods

Chemicals and reagents

α-Amylase, porcine PL, orlistat, acarbose, gallic acid, ascorbic acid, quercetin, 1,1-diphenyl-2-picrylhydrazyl radical (DPPH), nitro blue tetrazolium, p-nitrophenyl palmitate (pNPP), dinitrosalicylic acid (DNS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), potassium bromide (KBr) pellets, aluminum chloride, sodium chloride, sodium nitroxide, sodium carbonate, and sodium phosphate buffer were purchased from CDH Chemicals, Delhi, India, and were of AR grade. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), streptomycin, and penicillin were purchased from Hi-Media Laboratories Ltd., Mumbai, India. AR grade methanol, chloroform, butanol, ethyl acetate, and dimethyl sulfoxide (DMSO) were obtained from Merck Ltd., Mumbai, India.

General experimental procedures

Infrared (IR) and ultraviolet (UV) spectra were measured on a Bio-Rad Fourier-Transform (FT)-IR Spectrometer (Spectra Lab Scientific Inc., Ontario, Canada) and Lambda Bio 20 Spectrometer (Perkin-Elmer, Rotkreuz, Switzerland), respectively. Nuclear Magnetic Resonance (NMR) spectra were recorded on Bruker Spectrospin Spectrometer (Bruker AXS, Karlsruhe, Germany) in CD3 OD or DMSO-d 6 using tetramethylsilane as an internal standard. Electrospray ionization mass spectrometry (ESI-MS) was recorded on a Waters Acquity (Micromass MS Technologies, Manchester, UK) Mass Spectrometer. Column chromatographic separation was carried out on silica gel (60–120 mesh, Merck, Mumbai, Maharashtra, India). Precoated silica gel 60 F254 thin layer chromatography (TLC) plates (Merck, Mumbai, Maharashtra, India) were used for comparison and pooling of eluents.

Collection of plant materials

Dried fruits of G. indica were purchased from the local crude drug market, Khari Baoli (Delhi, India). The fruits were authenticated by Dr. H. B. Singh, Former Chief Scientist, CSIR-NISCAIR, Delhi. A voucher specimen of drug has been deposited in the Departments of Phytochemistry and Pharmacognosy at our institute with a reference number PRL-21/2015.

Fractionation and isolation of compounds

Dried G. indica fruits (1 kg) were dried, pulverized, and extracted with methanol (10 l) till exhaustion using a Soxhlet apparatus. The methanolic extract (FGIME) was filtered and concentrated in vacou using Rotavapor (Buchi, Switzerland) to get a semisolid residue (251 g). The residue was then dissolved in distilled water and partitioned sequentially with different solvents to yield ethyl acetate, chloroform, and aqueous fractions of fruits of G. indica that were designated as FGIEF, FGICF, and FGIAF, respectively. The fractions of fruits of G. indica were concentrated using Rotavapor, and the air-dried residues were kept in a refrigerator until further use.

FGIEF was subjected to normal-phase medium-pressure liquid chromatography (MPLC) for the isolation of compounds. The isolation was performed on Easy Purification System (Buchi, Flawil, Switzerland) having two pump modules (C-605), a control unit (C-615), and a UV detector (C-640). Fractionation was carried out using a 70 mm × 460 mm plastic-glass column packed with silica gel Si60 (50–60 μm). The FGIEF was homogenized, filtered, and loaded on to the column through the injector loop. Initially, the column was eluted with hexane–ethyl acetate mixtures. For running out simultaneous detection, eluents were detected by an online UV detector set at 225, 254, 277, and 330 nm. Fractions were collected manually based on the changes in absorbance. Aliquots were analyzed by on precoated TLC plates before pooling. Finally, they were processed further to obtain compounds 1–3. The purity of compounds was ascertained on Prominence High-Performance Liquid Chromatography with Diode Array Detector System (Shimadzu, Japan) fitted with a UV-visible (UV-Vis) detector (SPD-M20A), an auto-sampler (SIL-20 AC HT), and a fraction collector-10A. Characterization of the isolated compounds was done based on spectral data analysis.

Estimation of total polyphenols content

Total polyphenols content (TPC) was estimated in all the fractions using Folin–Ciocalteu method.[15] Each fraction was diluted to prepare a stock solution (10 mg/mL). Test sample solution (100 μl) of different fractions was mixed with 500 μL of Folin–Ciocalteu's reagent and 400 μL sodium carbonate (20%) and incubated at 25°C–27°C for 90 min. The absorbance was measured at 760 nm using UV-Vis spectrophotometer (JASCO V-550, Japan). TPC was expressed as milligram gallic acid equivalent (GAE) per gram of the test samples.

Estimation of total flavonoids content

The aluminum trichloride assay was performed to measure total flavonoid content (TFC) of all the fractions with slight modifications.[16] Test samples were dissolved in 10% DMSO to yield 500 μg/mL solution that was mixed with 150 μL of 5 M NaNO2. After 5 min, 150 μL of 10% aqueous AlCl3 was added to the mixture followed by 1 mL of 1 M NaOH. After 15 min of incubation, the absorbance was measured at 510 nm on UV-Vis spectrophotometer. All measurements were repeated thrice. A calibration curve of standard reference was assessed as quercetin equivalent in milligrams per gram of test sample.

In vitro pancreatic lipase inhibitory assay

PL inhibitory activity of FGIEF was determined by spectroscopic estimation.[17] Briefly, pNPP hydrolyzed by PL to p-nitrophenol is monitored at 410 nm. The assay mixtures composed of 1.8 ml sodium phosphate buffer (0.05 M, pH 7.6), 1.15 mg/mL sodium cholate, 0.55 mg/mL Arabic gum, 0.2 mL pNPP in isopropanol (0.01 M), and 0.02 mL of FGIEF (at different concentrations) were incubated at 37°C. Then, 0.02 ml of the PL solution in sodium phosphate buffer (50 mg/mL) was added to initiate the reaction. After 5 min of incubation at 37°C, the absorbance was recorded at 410 nm. The control reaction was carried out without adding FGIEF.

In vitro α-amylase inhibitory assay

α-Amylase inhibition assay was carried out as per the method described by Dong et al ., 2012.[18] α-Amylase (40 μL of 5U/mL) in 0.36 mL of sodium phosphate buffer (0.02 M, pH 6.9 containing 0.006 M NaCl) was mixed with 0.2 mL of FGIEF or acarbose. The mixture was incubated for 20 min at 25°C and 300 μL of starch solution (1% in 0.02 M sodium phosphate buffer) was added, the mixture was incubated again for 20 min at 25°C. The reaction was stopped by addition of 0.2 mL of DNS, the contents were kept in a boiling water bath for 5 min, and the absorbance was recorded at 540 nm The control reaction was carried out without adding FGIEF.

The percentage of enzyme inhibition was determined as:


Where Atest and Acontrol represent the absorbance of reaction mixture with and without test sample, respectively. IC50 values represented concentration of samples required for inhibiting 50% of enzyme activity under the assay conditions.

Estimation of antioxidant activity by 1,1-diphenyl-2-picrylhydrazyl radical method

DPPH method was used to determine the antioxidant activity of test samples (extract as well as its fractions) taking ascorbic acid as control with minor modifications.[19] Precisely, 1 mL from methanolic solution of DPPH (0.3 mM) was added to 2.5 mL of test samples (100–500 μg/mL). The resultant mixtures were kept in the dark for 30 min, and the absorbance was measured at 517 nm against blank that did not contain DPPH. A decrease in absorbance recorded for DPPH solution indicated an increase of DPPH radical scavenging activity. The measurements were repeated thrice and the scavenging activity was calculated as:


Where Atest and Acontrol represent the absorbance of the reaction mixture with and without test sample, respectively. The percentage inhibition was plotted against log concentration for the calculation of IC50.

Cell viability 3-(4, 5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide assay

3T3-L1 preadipocyte cells were obtained from the National Centre for Cell Science, Pune. Cells were maintained in DMEM containing 10% FBS and 1% penicillin and streptomycin in a humidified 5% CO2 atmosphere at 37°C. The cells were cultured at in a 96-well plate (5 × 104 cells/mL) to evaluate the cytotoxicity of FGIEF. The cells were treated with different concentrations ranging from 100 to 2000 mg/mL for 48 h. It was followed by the incubation of cells with MTT solution for 3 h at 37°C under a humidified 5% CO2 atmosphere. The supernatants were aspirated, DMSO was added to each well, and the absorbance was measured at 570 nm using a microwell plate reader. The cytotoxicity of the test samples was estimated by comparing their absorbance values with the untreated control cells.

Docking study for representative polyphenols

Representative polyphenols, namely cyanidin, proanthocyanidin, and flavanoyl flavone, and the compounds isolated from G. indica were docked with PL enzyme to assess their interaction and binding modes with the target enzyme using Glide extra precision (XP) Maestro 10.1 Schrodinger, running on Linux 64 Operating System (Schrodinger, Version 10.1, 2016, LLC, New York, USA). PL is a validated target for anti-obesity drug, and the crystal structure was downloaded from protein data bank (PDB 1 LPB). Two-dimensional (2D) structures for the test compounds were converted to their respective 3-dimensional (3D) structures using LigPlot. Protein preparation wizard in Maestro 10.5 was used to complete the protein preparation through preprocess, review, and refinement. Methoxyundecyl phosphinic acid was used as co-crystal ligand for the grid. This followed replacing all the water molecules by hydrogen atoms. The energy of the structures and ligands was minimized using Optimized Potential for Liquid Simulations (OPLS) 2005 force field. The ligand was docked into the grid generated from the protein and the glide score was recorded.

Prime molecular mechanics/generalized born surface area (MM-GBSA) was calculated using Maestro 10.5. The test compounds and orlistat were used against PL enzyme (PDB ID-1 LPB). Protein preparation and the ligand preparation were followed by deleting all the water molecules. The free binding energy calculation was undertaken using model prime MM-GBSA. Alternatively, the results were procured by running the program directly from the file generated by running the docking protocol.

Statistical analysis

All data were presented as an average of triplicate determinations ± standard deviation (SD). Statistical analysis was performed by one-way analysis of variance followed by Dunnett's multiple comparison test (GraphPad® InStat version 3.06, San Diego California, USA). P < 0.05 was considered to be statistically significant.


Total polyphenols content and total flavonoids content of Garcinia indica fruits

The results of TPC and TFC for the methanolic extract of the fruits of G. indica and its fractions are mentioned in [Table 1]. Highest values for TPC (375.6 ± 4.5 GAE mg/g) and TFC (235.5 ± 6.2 QE mg/g) were found in ethyl acetate fraction of the fruits followed by chloroform, butanol, and aqueous fraction [Table 1].{Table 1}

Inhibition of digestive enzymes

The results of PL and α-amylase inhibition assay are presented in [Figure 1] and [Table 2]. As shown in [Figure 1], all the fractions of the methanolic extract of G. indica fruits exhibited a concentration-dependent inhibition of PL and α-amylase. All tested fractions were stronger PL inhibitors than the α-amylase inhibitors [Table 2]. Highest ability to reduce PL activity was demonstrated by the ethyl acetate fraction, FGIEF (72.7% at 500 μg/mL) with the IC50 value of 257.3 ± 3.7 μg/mL. Similarly, FGIEF possessed the highest inhibition of α-amylase enzyme (71.7% at 500 μg/mL) with the IC50 value of 349.7 ± 5.8 μg/mL. The aqueous fraction exhibited the lowest inhibitory activity for both the enzymes. However, all the tested extract and fractions were less active than the standard positive controls, PL inhibitor orlistat (IC50 value 100.8 ± 2.6 μg/mL) and α-amylase inhibitor acarbose (113.7 ± 2.3 μg/mL). These results correlated well with the results of TPC and TFC estimation.{Figure 1}{Table 2}

In vitro antioxidant activity

The results of DPPH inhibition assay for the methanolic extract and fractions of fruits of G. indica are demonstrated in [Figure 2]. Among the fractions, FGIEF showed the highest antioxidant activity (68.8% at 500 μg/mL) with an IC50 value of 294.3 ± 2.3 μg/mL. Other fractions showed relatively lesser DPPH inhibition in the order of FGICF (318.5 ± 3.3 μg/mL), FGIBF (329.8 ± 4.0 μg/mL), and FGIAF (495.1 ± 2.4 μg/mL). The IC50 value of FGIME was reported to be 514.5 ± 5.1 μg/mL while that of the standard ascorbic acid was 97.5 ± 3.2 μg/mL. These results were in agreement with the results of TPC and TFC estimation.{Figure 2}

Effect of fractions on 3T3-L1 cell viability using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay

The effect of FGIEF on cell viability was evaluated by MTT assay using 3T3-L1 preadipocytes. FGIEF did not induce any cell death up to the dose of 800 mg/mL beyond which the cell viability decreased in a dose-dependent manner [Figure 3]. Accordingly, the concentrations of FGIEF up to 500 mg/mL were used for further studies.{Figure 3}

Characterization of compounds isolated from Garcinica indica fruits

MPLC of FGIEF resulted in the isolation of three compounds 1–3. The structures of the isolated compounds [Table 3] were elucidated on the basis of spectral data analysis.{Table 3}

Luteolin (1)

Eluent: 25% ethyl acetate in hexane; FTIR νmax(KBr): 3396, 2925, 2810, 1664, 1610, 1569, 1443, 1259, 1031 cm−1;1 H NMR (CD3 OD): δ 7.35 (d, J = 2.0 Hz, H-8), 7.36 (d, J = 8.0 Hz, H-6'), 6.88 (d, J = 8.0 Hz, H-5'), 6.53 (s, H-3), 6.43 (d, J = 2.5 Hz, H-2'), 6.19 (d, J = 2.0 Hz, H-6);13 C NMR (CD3 OD): δ (C2-10) 166.0, 100.1, 183.8, 163.2, 100.1, 166.3, 94.9, 159.4, 103.8; (C1'-6') 123.6, 114.0, 147.0, 150.9, 116.7, 120.2; +ve ESI-MS: 287 [M + H] + C15H11O6; HR-ESI-MS: C15H11O6[M + H] +287.0537 (observed), 287.0511 (calculated).

Napthyldioxolol (2)

Eluent: 80% ethyl acetate in hexane; FTIR νmax(KBr): 3488, 3274, 1669, 1623, 1427, 1229, 1160 cm−1;1 H NMR (CD3 OD): δ 7.78 (d, J = 2.5 Hz, H-5), 7.26 (d, J = 8.5 Hz, H-3), 7.12 (dd, J = 3.0, 8.5 Hz, H-4), 7.07 (s, H-7), 4.84 (br s, H2-11);13 C NMR (CD3 OD): δ (C1-11) 145.2, 133.2, 112.5, 114.7, 108.7, 134.1, 108.7, 158.7, 109.7, 124.5, 101.9;-ve ESI-MS: 204 [M] C11H8O4; HR-ESI-MS: C11H8O4[M] 204.0284 (observed), 204.0423 (calculated).

Oleantrienoic acid glucoside (3)

Eluent: 95% ethyl acetate in hexane; FTIR νmax(KBr): 3422, 2932, 2841, 1740, 1637, 1459, 1072 cm−1;1 H NMR (DMSO-d 6): δ 5.33 (d, J = 5.0 Hz, H-11), 4.85 (d, J = 5.0 Hz, H-12), 4.80 (br d, H-6), 4.41 (br s, H-3), 4.22 (d, J = 8.0 Hz, H-1'), 3.40 (dd, J = 4.0, 12.0 Hz, H2-6'), 1.43 (s, H3-26), 1.02 (s, H3-24), 0.98 (s, H3-23), 0.90 (s, H3-30, H3-27), 0.86 (s, H3-25), 0.65 (s, H3-29);13 C NMR (DMSO-d 6): δ (C1-29) 39.0, 18.9, 76.7, 36.8, 140.4, 116.0, 35.9, 41.8, 163.9, 44.2, 116.5, 121., 156.4, 43.5, 28.7, 22.6, 46.2, 41.2, 45.4, 31.4, 33.4, 36.5, 11.6, 22.6, 23.6, 24.5, 27.6, 182.7, 32.0), 21.5; (C1'-6') 100.7, 73.4, 76.7, 70.1, 81.4, 61.1; +ve ESI-MS: 615 [M + H] + C36H55O8; HR-ESI-MS: C36H55O8[M + H] +615.3973 (observed), 615.3852 (calculated).

Docking studies of representative polyphenols and compounds isolated from Garcinica indica fruits

The docking study was carried out to know the binding mode of the representative polyphenols (cyanidin, proanthocyanidin, and flavanoyl flavone) and the compounds isolated from G. indica fruits inside the PL receptor binding pocket. Orlistat was used as the standard for comparison. The molecular docking studies were undertaken using PL as a target protein. This was done to assess the binding ability of the compounds at the PL-colipase complex binding site. The docking scores of the tested compounds and co-crystal ligand methoxyundecyl phosphinic acid are presented in [Table 3]. Tested polyphenols showed hydrogen bond interaction with different residues and were compared with orlistat [Figure 4]a, [Figure 4]b, [Figure 4]c [Figure 4]d. The results revealed that proanthocyanidin shows key hydrogen bond interaction with Asp 79, Phe77, Leu 153, and Ser152, similar to the hydrogen binding interaction shown by the standard drug orlistat. Proanthocyanidin shows additional hydrogen bond with Glu179 and Tyr114 that may be the reason for more strong binding with the receptors. The docking score of the proanthocyanidin was found to be −6.545, which is higher than the orlistat (−5.402). Cyanidin and flavanonyl flavone also possessed higher docking score than orlistat showing more binding affinity. The results of free binding energy showed that the polyphenols fit into the PL binding domain (PDB ID-1 LPB). The binding energy was in the range of −36.49 to −49.95 Kcal/mol. The binding energy of proanthocyanidin was found to be −49.95 Kcal/mol, which is higher than the standard drug orlistat (−47.41 Kcal/mol). Other two docked polyphenols, named cyanidin and flavanonyl flavone, possessed low binding energy than proanthocyanidin and standard drug.{Figure 4}

The isolated compounds were found to strongly inhibit PL by completely occupying the active sites in the target protein. All inhibitors showed good docking scores than the co-crystal ligand, taken as the standard. Among all the titled compounds for the receptor, oleantrienoic acid glucoside was found to be most potent and has high docking score of −10.11. This ligand also assumes favorable orientation within the PL-colipase complex binding site. The binding mode of oleantrienoic acid glucoside is exactly the same as the co-crystal ligand. The 2D docked pose of oleantrienoic acid glucoside possesses two hydrogen bond interactions, among which one of the hydroxyl group attached at 3-glycoside formed H-bond with a backbone residue PHE 77 and other 6-methyl hydroxy of glycoside group formed a hydrogen-bond with a side chain residue HIE 151. Strong interaction with a backbone residue of oleantrienoic acid glucoside is the reason for its high affinity. All hydrogen interactions of receptor-oleantrienoic acid glucoside complex in 3D-image are represented in [Figure 4]e. The docked pose of second most dock ranked ligand luteolin (docking score of −9.46), the hydroxyl group of dihydroxy chromen-4-one forms hydrogen bond with both HIE 151 (side chain residue) and GLY 76 (backbone residue) as exhibited by oleantrienoic acid glucoside. One more similar pi–pi interaction was obtained by phenyl ring of dihydroxy phenyl ring at the second position of luteolin with backbone residue PHE 77. Both rings of chromen-4-one form pi-cation with HIP 263 which fills the compounds' account with penalties, and hence, it fell on the second position with docking score less than oleantrienoic acid glucoside [Table 3]. The interactions exhibited by the luteolin are shown in [Figure 4]f. The third ligand napthyldioxolol possess only one hydrogen bond of hydroxyl group with SER 152, which is a side chain residue and hence possesses least score of −8.19 among all three ligands. The 3D docked pose of napthyldioxolol is shown in [Figure 4]g.

The results related to the free binding energy showed that all the compounds fitted well in the PL binding domain [Table 3]. The best one among them, i.e., oleantrienoic acid glucoside, has more suitable conformation to fit into the domain. The binding energy ranged between −35.000 and −44.021 Kcal/mol. The binding energy of the test compound luteolin was found to be −44.021 which is comparable to orlistat (−47.41 Kcal/mol).

In vitro pancreatic lipase inhibitory activity of the isolated compounds

As a follow of docking studies, the isolated compounds were tested for PL inhibitory activity in vitro . The results were not found to be in complete agreement with the results of docking study of the three compounds. Napthyldioxolol (2) possessed the lowest IC50 value followed by luteolin (1) and oleantrienoic acid glucoside (3). The results are presented in [Table 3].


In the last few decades, obesity has emerged as a pandemic medical condition and its effective management has caught the attention of biomedical researchers and dieticians and to the end users. Obesity results from an altered metabolism of fat and carbohydrate besides oxidative stress. Currently, the management of obesity is through lifestyle modifications, pharmacotherapy, and surgical interventions. The lifestyle modifications fail due to poor compliance by the patients on long-term basis. Orlistat, a PL inhibitor, is the only Food and Drug Administration-approved drug used clinically for obesity. It suffers from various unpleasant gastrointestinal adverse reactions such as bloating and oily stools together with decrease in fat-soluble vitamin absorption. Surgical interventions include restricted and malabsorptive procedures such as bariatric surgeries. These procedures are usually twinned with side effects on human health.[20] Thus, the hunt for improved pharmacotherapies for obesity continues till date.

In the quest for the alternatives to anti-obesity therapeutics, nutraceuticals are fast emerging as an alternative approach. Development of functional foods by incorporating bioactive plant components in the food is the new trend to control body weight gain in obese population or those who are susceptible to obesity. This becomes possible by supplementation of food with substances that inhibit fat and carbohydrate metabolism. Their consumption may also induce satiety or feeling of fullness, thereby deterring the patient from overeating. Polyphenols have been found to be capable of lowering plasma free fatty acid levels, hepatic lipid accumulation, and body weight by increasing lipolysis, lowering food intake, and inhibiting adipocyte differentiation.[21] Dietary polyphenols exert their protective action against oxidative stress by neutralizing free radicals and decreasing oxidative inflammatory status associated with the weight gain.[22] Digestive enzyme (PL and α-amylase) inhibitors from natural food sources play an essential role in weight loss process. PL inhibitors from natural products act peripherally by inhibiting fat digestion and absorption and decrease the chances of systemic side effects. Inhibition of α-amylase enzyme increases the amount of undigested food in the intestine and delays gastric emptying and food intake.[23] Some clinical trials also demonstrated the beneficial role of polyphenols in reducing body weight.[24],[25]

In this study, we evaluated the role of polyphenol-rich fraction from G. indica fruits in the inhibition of digestive enzymes and oxidative stress that are considered to be responsible for obesity. The results of TPC and TFC for the methanolic extract and the fractions of G. indica of fruits presented in [Table 1] indicated the highest values for TPC (375.6 ± 4.5 GAE mg/g) and TFC (235.5 ± 6.2 QE mg/g) for ethyl acetate fraction of the fruits. Ethyl acetate fractions from plants have been reported to be enriched with a number of polyphenols.[26]

High phenolic content of the fruit supports antioxidant potential of G. indica fruits as depicted by DPPH activity. Among the fractions, FGIEF again showed highest antioxidant activity (68.8% at 500 μg/mL) with an IC50 value of 294.3 ± 2.3 μg/mL. The other fractions showed relatively lesser DPPH inhibition. These results were in good agreement with the results of TPC and TFC estimation. Therefore, the potent antioxidant effect of the fruit might contribute to its anti-obesity effect which has been indicated by the inhibition of PL and α-amylase enzymes. Similar anti-obesity potential has been demonstrated by antioxidant fractions of the Saskatoon berry.[27] The results of the MTT assay clearly established the safety of FGIEF as it did not affect preadipocytes up to the dose of 800 mg/mL beyond which the cell viability decreased in a dose-dependent manner [Figure 3]. Accordingly, concentrations of FGIEF up to 500 mg/mL were used for further studies.

The results of PL and α-amylase inhibition assay presented in [Figure 1] and [Table 2] indicated that the ethyl acetate fraction (FGIEF) had the highest ability to reduce the PL activity with the IC50 value 257.3 ± 3.7 μg/mL. Similarly, FGIEF possessed the highest inhibition of α-amylase enzyme with the IC50 value of 349.7 ± 5.8 μg/mL. Our study proved a direct correlation between the total polyphenols and flavonoids contents and the inhibition of digestive enzymes. Low antilipase and α-amylase activities exhibited by the methanolic extract of the fruit can be due to the presence of nonphenolic plant components, such as sugars, pigments, and acids. Remarkably, all tested samples possessed higher PL inhibition than the α-amylase inhibition. This is in accordance with the previous reports that showed polyphenol-enriched compositions as potent inhibitor of PL than the α-amylase.[28] However, the tested samples were lesser potent than orlistat. The weaker effect of extract and its fractions may be due to the complexity of composition and lesser binding affinity of non-phenolic components. Thus, it can be safely concluded that the anti-obesity effect of G. indica fruits may be partly linked to its inhibitory activity against PL and α-amylase enzymes, leading to the attenuation of dietary fat and carbohydrate absorption in the gastrointestinal tract.

After this bioactivity-guided fractionation of methanolic extract of G. indica fruits, FGIEF was subjected to MPLC for the isolation of active compounds. Three compounds (1–3) were isolated and their chemical structures of compounds were elucidated based on spectral data. Compound 1 was found to be luteolin on the basis of comparison of spectral data reported earlier.[29] Compound 2, named as napthyldioxolol, consisted of cream-colored crystals from 80% ethyl acetate in hexane eluents. FTIR spectrum exhibited absorption bands for hydroxyl (3488, 3274 cm−1) and aromatic (1623, 1427 cm−1) functionalities. Based on13 C NMR and mass spectral data, the molecular mass of 2 was established at 204 that was consistent with the molecular formula C11H8O4. The mass spectrum displayed a base peak at m/z 160 corresponding to (C10H10O4) that arose due to fission of dioxole ring.1 H NMR spectrum of 2exhibited signals for aromatic protons at δ 7.78 (d, J = 2.5 Hz, H-5), 7.26 (d, J = 8.5 Hz, H-3), 7.12 (dd, J = 3.0, 8.5 Hz, H-4), and 7.07 (br s, H-7), indicating the presence of an ABX system. It also displayed a two-proton singlet at δ 4.84 attributed to dioxymethylene protons (H2-11). The13 C NMR spectrum of two displayed signals for 11 carbons that consisted of four oxygenated aromatic carbons, six aromatic carbons, and a dioxymethylene carbon. Therefore, compound 2 was characterized as naphtha [1, 2-d] [1, 3] dioxole-6, 8-diol.

Compound 3, named as oleantrienoic acid glucoside, consisted of a light green waxy mass from 95% ethyl acetate in hexane eluents. FTIR spectrum displayed bands for the presence of hyrdoxyl (3422 cm−1), carboxyl (1740 cm−1), and vinylic (1670 cm−1) functionalities. Its molecular mass was established at m/z 614 based on NMR and mass spectrum. It was consistent with the molecular formula C36H54O8. The fragment ion peaks at m/z 433 (C30H41O2) + arouse due to glycosodic fission. The fragment ion peak at m/z 206 and 228 appeared due to retro-Diels Alder fission.1 H NMR spectrum of 3 exhibited two one-proton doublets at δ 5.33 and 4.85 (J = 5.0 Hz) and a broad signal at δ 5.39 (1H) ascribed correspondingly to H-11, H-12, and H-6 vinylic protons. A broad signal at δ 4.41 integrating for one proton was assigned to H-3 carbinol proton. A doublet at δ 4.22 (J = 8.0 Hz) was accounted to anomeric protons H-1'. The other sugar protons appeared from δ 4.04 to 3.40. Five three-proton singlets at δ 1.43, 1.02, 0.98, 0.86, and 0.65 were ascribed to Me-26, Me-24, Me-23, Me-25, and Me-29 protons, respectively. A six-proton singlet at δ 0.90 was attributed to Me-27 and Me-30 methyl protons.13 C NMR spectrum of 3 displayed important signals for carboxyl carbon at δ 182.7 (C-28); vinylic carbons from δ 156.3 to 116.0; and anomeric carbon at δ 100.7 (C-1). The methyl carbons resonated between δ 32.0 and 11.6. On acid hydrolysis, compound 3 yielded D-glucose. Thus, compound 3 was elucidated to be olean-5, 9 (11), 12-trien-28-oic acid-3-ol-3-O -β-D-glucopyranose.

Nowadays, in silico studies are pursued to simulate the interaction of test substance with its target. We also carried out docking modeling to study the interaction of representative polyphenols and isolated compounds with PL. The results presented in [Table 3] showed strongest interaction of oleantrienoic acid glucoside among the tested substances as it assumed favorable orientation within the PL-colipase complex binding site. The polyphenols exhibited significant antilipase activities but weaker than the orlistat. Our results are in line with previous reports on PL inhibition by polyphenol-rich ethyl acetate fraction from different plants.[30],[31] Polyphenol-rich grape seed extract has been reported to reduce dietary fat absorption through PL inhibition and slow down the accumulation of fat in adipose tissue.[32] Similarly, ethyl acetate fraction of Terminalia chebula diminishes obesity by reducing lipid accumulation through suppression of digestive enzymes such as PL and amylase and 3T3-L1 adipocyte differentiation.[33] Recently, phenolic acid-rich fruit extracts of Cornus mas and Cornus alba have been shown to have antiobesogenic effects by inhibiting PL and α-amylase enzymes.[28] The results of the docking studies involving isolated compounds were not in complete concordance with theirin vitro PL inhibitory activity. This observation also highlights the need to follow-up in silico studies within vitro tests.


The fruits of G. indica exhibit anti-obesity effect through the inhibition of digestive enzymes that can be mainly attributed to the presence of polyphenols. G. indica fruit berries, particularly its polyphenol-enriched fraction, causes the amelioration of obesogenic and oxidative stress. The study also emphasized the potential of this edible fruit as a novel food ingredient to be pursued as a nutraceutical or a dietary supplement. Further, in depth studies on the experimental animals and humans can pave its way to market as an anti-obesity agent.


We sincerely thank Prof. Mohammad Ali for his suggestions and Dr. M. S. Yar, Jamia Hamdard, Delhi for carrying out docking studies. We also wish to thank Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India, for recording NMR and Mass Spectra.

Financial support and sponsorship

We thank Indian Council of Medical Research for the financial support for this work (Grant no 45/3/2018/TM/BMS) and AICTE for providing the infrastructural support (Grant No. 8-71/RIFD/RPS/POLICY-1/2016-17).

Conflicts of interest

There are no conflicts of interest.


1WHO, Facts about Overweight and Obesity. Available from: [Last accessed on 2020 Jan14].
2Assis-Coelho RC. Anti-obesity drugs: A necessary part of treatment. J Obesity Weight-Loss Medic 2015;1:1-2.
3Dawes AJ, Maggard-Gibbons M, Maher AR, Booth MJ, Miake-Lye I, Beroes JM, et al . Mental health conditions among patients seeking and undergoing bariatric surgery: A meta-analysis. JAMA 2016;315:150-63.
4Marrelli M, Loizzo MR, Nicoletti M, Menichini F, Conforti F.In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti-obesity agents with α-amylase and pancreatic lipase inhibitory activities. J Sci Food Agric 2014;94:2217-24.
5Baliga MS, Bhat HP, Pai RJ, Boloor R, Palatty PL. The chemistry and medicinal uses of the underutilized Indian fruit tree Garcinia indica Choisy (Kokum ): A review. Food Res Int 2011;44:1790-9.
6Jagtap P, Bhise K, Prakya VA. Phytopharmacological review on Garcinia indica . Int J Herb Med 2015;3:2-7.
7Lakshmi C, Kumar KA, Dennis TJ, Kumar TS. Antibacterial activity of polyphenols of Garcinia indica . Indian J Pharm Sci 2011;73:470-3.
8Jayaprakasha GK, Sakariah KK. Determination of organic acids in leaves and rinds of Garcinia indica (Desr.) by LC. J Pharm Biomed Anal 2002;28:379-84.
9Nayak CA, Srinivas P, Rastogi NK. Characterisation of anthocyanins from Garcinia indica Choisy. Food Chem 2010;118:719-24.
10Chattopadhyay SK, Kumar S. Identification and quantification of two biologically active polyisoprenylated benzophenones xanthochymol and isoxanthochymol in Garcinia species using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006;844:67-83.
11Rao VG, Karunakara AC, Babu SR, Ranjit D, Reddy CG. Hydroxycitric acid lactone and its salts: Preparation and appetite suppression studies. Food Chem 2010;120:235-9.
12Lee PS, Teng CY, Kalyanam N, Ho CT, Pan MH. Garcinol reduces obesity in high-fat-diet-fed mice by modulating gut microbiota composition. Mol Nutr Food Res 2019;63:e1800390.
13Liu C, Ho PC, Wong FC, Sethi G, Wang LZ, Goh BC. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Lett 2015;362:8-14.
14Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 2010;13:631-43.
15Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 1999;299:152-78.
16Zhishen J, Mengchng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 1999;64:555-9.
17Winkler UK, Stuckmann M. Glycogen, hyaluronate, and some other polysaccharides greatly enhance the formation of exolipase by Serratia marcescens . J Bacteriol 1979;138:663-70.
18Dong HQ, Li M, Zhu F, Liu FL, Huang JB. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. Food Chem 2012;130:261-6.
19D'Angelo S, Morana A, Salvatore A, Zappia V, Galletti P. Protective effect of polyphenols from Glycyrrhiza glabra against oxidative stress in Caco-2 cells. J Med Food 2009;12:1326-33.
20Kang JG, Park CY. Anti-obesity drugs: A review about their effects and safety. Diabetes Metab J 2012;36:13-25.
21Park HJ, Jung UJ, Lee MK, Cho SJ, Jung HK, Hong JH, et al . Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice. Mol Nutr Food Res 2013;57:360-4.
22Bowtell J, Kelly V. Fruitderived polyphenol supplementation for athlete recovery and performance. Sports Med 2019;49:3-23.
23Tucci SA, Boyland EJ, Halford JC. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: A review of current and emerging therapeutic agents. Diabetes Metab Syndr Obes 2010;3:125-43.
24Chiva-Blanch G, Badimon L. Effects of polyphenol intake on metabolic syndrome: Current evidences from human trials. Oxid Med Cell Longev 2017;2017. doi: 10.1155/2017/5812401.
25Farhat G, Drummond S, Al-Dujaili EAS. Polyphenols and their role in obesity management: A systematic review of randomized clinical trials. Phytother Res 2017;31:1005-18.
26Chakraborty M, Bala A, Bhattacharya S, Halder PK. Hypoglycemic effect of ethyl acetate fraction of methanol extract from Campylandra aurantiaca rhizome on high-fat diet and low-dose streptozotocin-induced diabetic rats. Pharmacogn Mag 2018;14:539-45.
27Lachowicz S, Wiśniewski R, Ochmian I, Drzymała K, Pluta S. Anti-microbiological, anti-hyperglycemic and anti-obesity potency of natural antioxidants in fruit fractions of Saskatoon berry. Antioxidants (Basel) 2019;8:1-18.
28Swierczewska A, Buchholz T, Melzig MF, Czerwinska ME.In vitro a-amylase and pancreatic lipase inhibitory activity of Cornus mas L. and Cornus alba L. fruit extracts. J Food Drug Anal 2019;27:249-58.
29Lin LC, Pai YF, Tsai TH. Isolation of luteolin and luteolin-7-O-glucoside from dendranthema morifolium ramat tzvel and their pharmacokinetics in rats. J Agric Food Chem 2015;63:7700-6.
30Les F, Arbonés-Mainar JM, Valero MS, López V. Pomegranate polyphenols and urolithin A inhibit α-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells. J Ethnopharmacol 2018;220:67-74.
31Sergent T, Vanderstraetem J, Winand J, Beguin P, Schneider YJ. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem 2012;135:68-73.
32Moreno DA, Ilic N, Poulev A, Brasaemle DL, Fried SK, Raskin I. Inhibitory effects of grape seed extract on lipases. Nutrition 2003;19:876-9.
33Borah AK, Kuri PR, Singh A, Saha S. Anti-adipogenic effect of Terminalia chebula fruit aqueous extract in 3T3-L1 preadipocytes. Pharmacogn Mag 2019;15:197-204.